REDWOOD CITY, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment conferences:
- 9th Annual Craig-Hallum Alpha Select Conference on Thursday, November 15, 2018. The conference is being held at the Sheraton New York Times Square Hotel in New York City;
- Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 15, 2018 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time). The conference is being held at the Westin Grand Central Hotel in New York City.
A live webcast and replay of the presentation at the Canaccord Genuity Medical Technology & Diagnostics Forum will be available on the Investors section of the company’s website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see www.codexis.com.
Contacts:
Investors
LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com